6 February 2024 - Public reimbursement for Vascepa is now available in Ontario, Quebec, British Columbia, Saskatchewan, New Brunswick, Northwest Territories, ...
17 January 2024 - 2023 was yet another dismal year for New Zealanders in terms of them being able to ...
21 December 2023 - Merck and Eisai announce that Keytruda plus Lenvima, is now reimbursed with clinical criteria and conditions ...
17 April 2023 - AbbVie today announced that Vraylat is now listed as an exception medication status on the list of ...
31 March 2023 - Mitsubishi Tanabe Pharma Canada is pleased to announce the company has entered into negotiations with the ...
6 February 2023 - First and only Bruton's tyrosine kinase inhibitor to be granted provincial formulary approval. ...
8 February 2023 - Santhera Pharmaceuticals announces that it has secured a final reimbursement agreement with the French authorities related to ...
7 February 2023 - Quebec public reimbursement coverage to facilitate and expand medication access for Parkinson’s patients in Quebec. ...
1 February 2023 - Medexus Pharmaceuticals wishes to inform investors that the company has reached an agreement with the provincial government ...
25 July 2022 - Reimbursement for Vascepa in Canada is now at more than 65% for publicly covered lives and private ...
19 July 2022 - On 8 July 2022, the German Health Ministry has officially shared the second edition of a new ...
13 July 2022 - Canada has seen a significant improvement in the number of Canadians eligible for some form of prescription ...
3 April 2022 - Bluebird bio is a highly innovative biotechnology company which develops gene therapies for several rare genetic ...
22 March 2022 - Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia. ...
20 October 2021 - Medical devices are potentially good candidates for coverage with evidence development schemes, as clinical data at market ...